| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | -0.31 | 0.06 |
| mRNA | lenalidomide | FIMM | pan-cancer | AAC | -0.28 | 0.1 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | -0.27 | 0.4 |
| mRNA | Cyclopamine | FIMM | pan-cancer | AAC | -0.26 | 0.1 |
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | -0.25 | 0.006 |
| mRNA | Epothilone B | FIMM | pan-cancer | AAC | -0.22 | 0.2 |
| mRNA | Methotrexate | FIMM | pan-cancer | AAC | -0.21 | 0.2 |
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | -0.2 | 0.02 |
| mRNA | Gefitinib | FIMM | pan-cancer | AAC | -0.19 | 0.3 |
| mRNA | Sunitinib | FIMM | pan-cancer | AAC | -0.18 | 0.4 |